<DOC>
	<DOCNO>NCT01524536</DOCNO>
	<brief_summary>Background : - Hypereosinophilic syndrome ( HES ) disorder body many eosinophil ( type white blood cell ) . Too many eosinophil HES cause damage heart , nerve , skin . Certain drug help low eosinophil count prevent tissue damage . Corticosteroids , prednisone , use initial therapy disorder . Although people respond prednisone , people develop side effect , respond well treatment . Better way determine dose give could help decide best therapy HES . Objectives : - To determine whether single-dose prednisone use predict people hypereosinophilia respond treatment . - To study lack response steroid treatment people HES . Eligibility : Inclusion criterion : - Individuals hypereosinophilic syndrome high eosinophil count . - Individuals willing blood drawn get steroid . Exclusion criterion : - Individuals 10mg prednisone ( similar drug ) - Individuals hypereosinophilic syndrome medication could interfere study - Women pregnant breast-feeding - Individuals know gene mutation associate chronic eosinophilic leukemia - Children le 18 year old weigh less 48kg 106lb Design : - Participants screen visit physical exam medical history . Blood urine sample collect . - Participants single dose steroid prednisone mouth morning . Blood sample collect 4 hour dose . - On day steroid dose , participant provide another blood sample morning . - Participants start take prednisone daily return home . Blood sample collect weekly participant doctor office . The dose prednisone lower depend weekly eosinophil count . We try get person low dose prednisone possible control disorder . Participants respond severe side effect take prednisone . Other treatment consider people respond steroid . The goal evaluate response prednisone . Our research try figure people respond steroid . Most people complete study within 6 16 week , depend response prednisone .</brief_summary>
	<brief_title>Steroid Treatment Hypereosinophilic Syndrome</brief_title>
	<detailed_description>This study aim develop model determine whether single , oral , weight-based dose glucocorticoid ( GC ) predict clinical biologic response GC long term subject hypereosinophilic syndrome ( HES ) . Subjects FIP1L1/PDGFRA-negative HES , symptomatic eosinophil count &gt; 1500/microL receive less equal to10 mg prednisone daily , enrol . A single oral dose prednisone ( 1 mg/kg round near 5mg ) administer . Eosinophil count various laboratory parameter assess 4 hour 24 hour follow prednisone administration ( investigator blind result eosinophil count ) . The subject begin GC therapy 30 mg prednisone daily follow standardized taper . The low dose GC symptom eosinophilia control compare change eosinophil count 4 24 hour post-challenge . Mechanisms vitro correlate GC resistance also explore .</detailed_description>
	<mesh_term>Hypereosinophilic Syndrome</mesh_term>
	<criteria>SUBJECT INCLUSION CRITERIA : Subjects Protocol # 94I0079 eligible participation study follow criterion apply : 1 . Subject meet diagnostic criterion HES ( AEC &gt; 1500/microL , absence secondary cause sign and/or symptom attributable eosinophilia ) 2 . Willingness perform time steroid challenge 3 . Appropriate candidate GC treatment challenge 4 . Willingness sample store future research SUBJECT EXCLUSION CRITERIA : A subject eligible participate study follow apply : 1 . Receiving &gt; 10 mg prednisone equivalent time enrollment . 2 . Receiving less equal 10 mg prednisone equivalent fix dose least 3 week ( subject current corticosteroid taper exclude ) . 3 . AEC le equal 1500/microl time enrollment . 4 . Use immunomodulatory medication , ( less equal 10 mg/day prednisone ) include limited biologics , within past 6 month . 5 . Pregnant time evaluation . 6 . Have know mutation FIP1L1PDGFR gene . 7 . Any condition , opinion investigator , place subject undue risk participate protocol . 8 . Weight le 48 kg ( 106 lb ) subject less 18 year age .</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>May 31, 2016</verification_date>
	<keyword>Hypereosinophilia</keyword>
	<keyword>Hypereosinophilic Syndrome</keyword>
	<keyword>Corticosteroids</keyword>
	<keyword>Therapy</keyword>
	<keyword>HES</keyword>
</DOC>